Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 24, Issue 1, 2004, Pages 137-142

  Hopkinson, N S ^a   Man, W D C ^b   Dayer, M J ^a   Ross, E T ^a   Nickol, A H ^a   Hart, N ^a   Moxham, J ^b   Polkey, M I ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Corticosteroids; Diaphgram; Exercise; Magnetic stimulation; Quadriceps

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; OXYGEN; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETER; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DIAPHRAGM; DISEASE ACTIVITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MUSCLE FUNCTION; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVE STIMULATION; OXYGEN THERAPY; PHRENIC NERVE; PREDICTION; PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUADRICEPS FEMORIS MUSCLE; RESPIRATORY FUNCTION; SNIFFING; STATISTICAL ANALYSIS;

ADRENAL CORTEX HORMONES; AGED; CASE-CONTROL STUDIES; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULOSKELETAL PHYSIOLOGY; PROBABILITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 3543118485     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00139003     Document Type: Article

References (36)

1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations. Johns Hopkins Med J 1932; 50: 137.
2. Nava S, Gayan-Ramirez G, Rollier H, et al. Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med 1996; 153: 1888-1896.
3. Viires N, Pavlovic D, Pariente R, Aubier M. Effects of steroids on diaphragmatic function in rats. Am Rev Respir Dis 1990; 142: 34-38.
4. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-634.
5. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
6. Hamilton A, Killian K, Summers E, Jones N. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
7. Decramer M, Lacquet L, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994; 150: 11-16.
8. Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964.
9. Weiner P, Azgad Y, Weiner M. The effect of corticosteroids on inspiratory muscle performance in humans. Chest 1993; 104: 1788-1791.
10. Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G. Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 2002; 20: 497-499.
11. Bowyer S, LaMothe M, Hollister J. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985; 76: 234-242.
12. Picado C, Fiz JA, Montserrat JM, et al. Respiratory and skeletal muscle function in steroid-dependent bronchial asthma. Am Rev Respir Dis 1990; 141: 14-20.
13. Wang YM, Zintel T, Vasquez A, Gallagher CG. Cortico-steroid therapy and respiratory muscle function in humans. Am Rev Respir Dis 1991; 144: 108-112.
14. Mills GH, Kyroussis D, Jenkins P, et al. Respiratory muscle strength in Cushing's syndrome. Am J Respir Crit Care Med 1999; 160: 1762-1765.
15. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52: Suppl. 5, S1-S28.
16. Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19: 626-631.
17. Edwards RHT, Young A, Hosking GP, Jones DA. Human skeletal muscle function: description of tests and normal values. Clin Sci (Lond) 1977; 52: 283-290.
18. Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996; 19: 549-555.
19. Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax 1984; 39: 535-538.
20. Miller JM, Moxham J, Green M. The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond) 1985; 69: 91-96.
21. Mills GH, Kyroussis D, Hamnegard CH, Polkey MI, Green M, Moxham J. Bilateral magnetic stimulation of the phrenic nerves from an anterolateral approach. Am J Respir Crit Care Med 1996; 154: 1099-1105.
22. Criner G, Cordova FC, Leyenson V, et al. Effect of lung volume reduction surgery on diaphragm strength. Am J Respir Crit Care Med 1998; 157: 1578-1585.
23. Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1310-1317.
24. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
25. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003; 58: 654-658.
26. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 1991; 114: 216-223.
27. Swinburn CR, Wakefield JM, Newman SP, Jones PW. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br J Clin Pharmacol 1988; 26: 709-713.
28. Man WD, Luo YM, Mustfa N, et al. Postprandial effects on twitch transdiaphragmatic pressure. Eur Respir J 2002; 20: 577-580.
29. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337: 1799-1806.
30. Man WD-C, Soliman MGG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 562-567.
31. Harris ML, Polkey MI, Bath PM, Moxham J. Quadriceps muscle weakness following acute hemiplegic stroke. Clin Rehabil 2001; 15: 274-281.
32. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7: 1793-1797.
33. Dentener MA, Creutzberg EC, Schols AM, et al. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 2001; 56: 721-726.
34. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003; 58: 752-756.
35. DuBois DC, Almon RR. Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors. Endocrinology 1980; 107: 1649-1651.
36. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-2867.